Ionis Pharmaceuticals (IONS) Divestments (2016 - 2017)

Ionis Pharmaceuticals' (IONS) quarterly Divestments came in at $2.5 million in Q1 2017, down 43.88% quarter-over-quarter from $4.5 million in Q4 2016.

Ionis Pharmaceuticals (IONS) Divestments (2016 - 2017) Analysis & Trends

Ionis Pharmaceuticals' Divestments history runs 2 years deep, the most recent figure standing at $2.5 million for Q1 2017.

  • On a quarterly basis, Divestments changed N/A year-over-year to $2.5 million in Q1 2017; TTM through Dec 2017 was $2.5 million, a 43.88% decrease from a year earlier, with the FY2017 full-year figure at $2.5 million, down 43.88% from the prior year.
  • Divestments slipped to $2.5 million in Q1 2017 per IONS's latest filing, from $4.5 million in the prior quarter.
  • Across five years, Divestments topped out at $4.5 million in Q4 2016 and bottomed at $2.5 million in Q1 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -32.58 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Ionis Pharmaceuticals 9.35 Bn 7.43 Bn 243.11 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2017 2.51 Mn
Dec 31, 2016 4.47 Mn